Jacmar: I will make a couple of comments about MNKD and

New Post Public Reply Private Reply Replies (1) Message Board
Chrisdc73 biotechexpert #14588
Jacmar: I will make a couple of comments about MNKD and then back to talking of AMBS. SNY reimburses COGS to MNKD and pays ALL marketing costs, regulatory costs, and follow on clinical trials. Do you have any idea how much that is? Large. There was also $150M upfront but there are milestone payments that takes that number to close to $1B. SNY also gave a line of credit to MNKD. SNY runs the show right now. Silence is golden. Breaking through the silence is that almost every insurer in the US is now covering Afrezza. Rumors are that SNY is training week of Jan 19th. Launch should follow very close after. In my opinion, the deal was set up to ensure MNKD existed until launch so they could add manufacturing lines and get the pipeline needed for launch. SNY does not need MNKD after that and my bet is SNY buys Afrezza. Rumors are that MDT may be involved somehow based on the SNY/MDT collaboration announced last year. Launch may not cause the share price to go parabolic because of the short position but it will go up. First hint of demand and price goes nuts. In my opinion, buyout is logical. Technosphere platform is also a factor here. In my opinion, Afrezza is worth minimum $40 per share. If you don't see it then watch it unfold from the sidelines. And, unless you are a doctor, I will forget more about diabetes than you likely know. This drug is a blockbuster. The end. Now let's talk AMBS.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 239

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Skyline Builders Group Secures $23.9 Million Funding for Growth

Updated Category News Views 271

Skyline Builders Group Holding Limited's Latest Private Placement Skyline Builders Group Holding Limited (NASDAQ: SKBL), a prominent civil engineering services provider in Hong Kong, has made headlines recently with its announcement of a significant funding initiative. The company is moving forward with a private placement that aims to raise an impressive $23.9 million....

Continue Reading
Target Hospitality's Q1 Results Highlight Strategic Growth Path

Updated Category News Views 124

Target Hospitality Delivers Impressive First Quarter Results Target Hospitality Corp. (NASDAQ: TH), a leading provider of integrated modular accommodations and hospitality services, has showcased its resilience and strategic growth during the first quarter. The company announced substantial results for its operations that concluded on March 31, 2025, marked by a keen...

Continue Reading
Why Estero, FL Is the New Hotspot for Relocation

Updated Category News Views 6

Escaping the Cold: A Migration to Estero It seems Estero, FL is becoming the new darling for those tired of shoveling snow. Marty Pecoraro from MP Realty Group spills the beans on why this sunny spot is pulling in folks from all corners. The Draw of a Warmer Lifestyle Forget just chasing sunshine. The trend of moving to Estero isn't about lounging in the sun like a...

Continue Reading
Pega's Global Expansion of Developer Training for Future Pros

Updated Category News Views 53

Pegasystems Inc (NASDAQ: PEGA) kicked off a major expansion of its Pega University Program, trying to tackle the escalating demand for software developers. This initiative had already shown promise in India and aimed to spread across North America, Europe, and Asia Pacific. Back then, the industry was choking on a talent shortage that had firms scrambling; projections...

Continue Reading
Pony AI's Robotaxi Service Revolutionizes Urban Transportation

Updated Category News Views 262

Introduction to Pony AI's Innovative Robotaxi Services Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY), renowned for its pioneering solutions in autonomous mobility, has marked a new chapter in urban transportation. The introduction of paid robotaxi services in the heart of Guangzhou is a groundbreaking move, connecting residents and travelers to major...

Continue Reading